Data / Form D filings / NeuraMedica Inc.
NeuraMedica Inc.: Form D filings
NeuraMedica Inc., a biotechnology company in Oregon City, OR, filed 5 Form D notices with the SEC between 2018 and 2024. The latest, on November 26, 2024, reports $709,622 sold of a $1 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 402 BEAVERCREEK RD, STE 110, Oregon City, OR, 97045
- Phone
- (503) 802-5533
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1744491
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Amendment | $1,000,000 | $709,622 | $290,378 | 13 | Jun 26, 2023 | sec.gov |
| Dec 11, 2023 | Amendment | $1,000,000 | $50,000 | $950,000 | 1 | Jun 26, 2023 | sec.gov |
| Jul 10, 2023 | New notice | $500,000 | $50,000 | $450,000 | 1 | Jun 26, 2023 | sec.gov |
| Feb 4, 2021 | New notice | $1,100,000 | $1,100,000 | 5 | Jan 28, 2021 | sec.gov | |
| Jun 22, 2018 | New notice | $150,000 | $40,000 | $110,000 | 2 | Jun 7, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Tippie | Director | |
| Neil Roundy | Executive Officer, Director, Promoter | |
| Rachel Dreilinger | Executive Officer, Director, Promoter |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Nov 25, 2024 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NeuraMedica Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.